ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Rheumatoid arthritis (RA)"

  • Abstract Number: 2490 • 2017 ACR/ARHP Annual Meeting

    Sustained Clinical Response in Refractory Rheumatoid Arthritis Patients with a Low-Dose Rituximab Retreatment Regimen. a Single Center Experience

    Sebastian C Rodriguez-Garcia, Raul Castellanos-Moreira Sr., M. Victoria Hernández, Andrea Cuervo, Virginia Ruiz-Esquide, Julio Ramírez, Juan Cañete and Raimon Sanmartí, Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain

    Background/Purpose: : The standard dose of rituximab (RTX) in rheumatoid arthritis (RA) is two intravenous (iv) 1 g infusions, separated by two weeks. Recently, the…
  • Abstract Number: 411 • 2017 ACR/ARHP Annual Meeting

    Factors That Drive Treatment Recommendation during Rheumatoid Arthritis Patient´s Follow-up, Differ According to Physician Experience

    César Sifuentes-Cantú1, Irazu Contreras-Yañez2, Lina Saldarriaga Rivera3, Ana Cecilia Lozada4, Marwin Gutierrez5 and Virginia Pascual-Ramos1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 3Instituto Nacional de Rehabilitación, Mexico, Mexico, 4Division of musculoskeletal and rheumatic diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico, 5Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico

    Background/Purpose: The management plan for rheumatoid arthritis (RA) might be a relatively simple task if only disease activity is considered but might become more complex…
  • Abstract Number: 848 • 2017 ACR/ARHP Annual Meeting

    “Suddenly You Are a Person at Risk of Developing Rheumatoid Arthritis!” Different Perspectives of Individuals on Predictive Testing – Results of an International Qualitative Interview Study

    Erika Mosor1, Michaela Stoffer2, Günter Steiner3, Karim Raza4, Rebecca J Stack4, Gwenda Simons4, Marie Falahee4, Georg Schett5, Matthias Englbrecht6, Josef S. Smolen2, Axel J. Hueber6 and Tanja Stamm7, 1Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria, 1090 Vienna, Austria, 2Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 3Rheumatology, Medical University of Vienna, Vienna, Austria, 4Department of Rheumatology, University of Birmingham and Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, UK, Birmingham, United Kingdom, 5Rheumatology and Immunology, Department of Internal Medicine 3, Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 6Department of Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 7Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Vienna, Austria

    Background/Purpose: People at risk of developing rheumatoid arthritis (RA) may be candidates for interventions aimed at preventing RA development [1]. The identification of such at…
  • Abstract Number: 2008 • 2017 ACR/ARHP Annual Meeting

    “Intrathoracic Manifestations of Connective Tissue Diseases on High Resolution Computed Tomography”

    Diego Baenas1, Maira Orozco2, María Eugenia Olmos3, Luis Lasca4, Paula Riba5, Patricio Muszinsky5, Juan Pablo Pirola6, Verónica Saurit7, Alejandro Alvarellos7, Ana C. Alvarez8, Soledad Retamozo9,10, Nadia Riscanevo7,11, Janet Flores12, Ariel Blua3, Ana María López13, Gustavo Muiño14, Santiago Orozco15 and Francisco Caeiro16, 1Rheumatology Unit, Hospital Privado Universitario de Córdoba, Postgraduate Career of Rheumatology Catholic University of Córdoba., Cordoba, Argentina, 2Radiology, Radiology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 3Pulmonary, Pulmonary Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 4Radiology Unit, Oulton Institute, Cordoba, Argentina, 5Radiology, Radiology Unit, Oulton Institute, Cordoba, Argentina, 6Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba., Cordoba, Argentina, 7Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 8Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Córdoba, Argentina, 9Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, 10Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, 11Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 12Rheumatology Unit, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 13Pulmonary Unit, Pulmonary Unit, Hospital Privado Universitario de Córdoba., Cordoba, Argentina, 14Radiology, Radiology Unit,Hospital Privado Universitario de Córdoba., Cordoba, Argentina, 15Radiology, Radiology Unit, Hospital Privado Universitario de Córdoba., Cordoba, Argentina, 16Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina

    Background/Purpose: Connective tissue diseases (CTD) can cause intrathoracic involvement, increasing patients morbidity and mortality. High-resolution computed tomography (HRCT) is a key method for evaluation of…
  • Abstract Number: 2795 • 2017 ACR/ARHP Annual Meeting

    Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized, Double-Blind Study

    Hans-Peter Tony1, Hendrik Schulze-Koops2, Klaus Krüger3, Stanley B Cohen4, Alan J. Kivitz5, Slawomir Jeka6, Edit Vereckei7, Liyi Cen8 and Dmitrij Kollins8, 1Department of Internal Medicine 2, Rheumatology and Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, 2Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany, 3Praxiszentrum St. Bonifatius München, München, Germany, 4Metroplex Clinical Research Centre, Dallas, TX, 5Altoona Center for Clinical Research, Duncansville, PA, 62nd University Hospital, CM UMK, Department of Rheumatology and Connective Tissue Diseases,, Bydgoszcz, Poland, 7National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, 8Clinical Development, Sandoz, a Novartis Division, Holzkirchen, Germany

    Background/Purpose: GP2013, is a biosimilar to European Union (EU) approved reference rituximab (RTX), developed in a stepwise approach that adheres to stringent biosimilar development guidelines.…
  • Abstract Number: 135 • 2016 ACR/ARHP Annual Meeting

    The 8-Joint Ultrasound Score Is a Useful Marker for Monitoring Therapeutic Response in Rheumatoid Arthritis

    Ryusuke Yoshimi1, Yukihiro Toyota1, Naomi Tsuchida1, Yumiko Sugiyama1, Yosuke Kunishita1, Daiga Kishimoto1, Reikou Kamiyama1, Kaoru Minegishi2, Maasa Tamura1, Yukiko Asami1, Yohei Kirino1, Shigeru Ohno2 and Hideaki Nakajima1, 1Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan, 2Center for Rheumatic Disease, Yokohama City University Medical Center, Yokohama, Japan

    Background/Purpose: Musculoskeletal ultrasonography (US) is one of the standard tools for the diagnosis and monitoring of rheumatoid arthritis (RA). Although we and other groups have…
  • Abstract Number: 1114 • 2016 ACR/ARHP Annual Meeting

    Extracellular Vesicles in the Circulating of Rheumatoid Arthritis Patients Are Pro-Inflammatory

    Onno J. Arntz1, Bartijn C.H. Pieters1, Rogier Thurlings2, Peter L. E. M. van Lent3, Peter M. van der Kraan3, Marije I. Koenders1, FHJ van den Hoogen2 and Fons A.J. van de Loo1, 1Experimental Rheumatology, Radboudumc, Nijmegen, Netherlands, 2Rheumatology, Radboudumc, Nijmegen, Netherlands, 3Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a progressive and degenerative joint disease with chronic synovial inflammation in multiple joints. Interestingly, the symmetry and spreading of the…
  • Abstract Number: 1973 • 2016 ACR/ARHP Annual Meeting

    Intramuscular Versus Ultrasound Guided Peritendinous Glucocorticoid Injection for Tenosynovitis in Patients with Rheumatoid Arthritis – a Randomised, Double-Blind, Controlled Study

    Mads Ammitzbøll-Danielsen1,2, Mikkel Ostergaard2,3, Viktoria Fana4, Daniel Glinatsi2,5, Uffe Møller Døhn6, Lykke Midtbøll Ørnbjerg7, Esperanza Naredo8 and Lene Terslev6, 1Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark, 2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, 3Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 4Center for Rheumatology and Spine Diseases, Rigshospitalet , Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark, 5Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Glostrup, Denmark, 6Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark, 7Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, 8Rheumatology, Hospital General Universitario Gregorio Marañón and Universidad Complutense, Madrid, Spain

    Background/Purpose:                                                              The aim of this study was to compare the efficacy of intramuscular versus ultrasound (US)-guided peritendinous glucocorticoid injection in providing disease control after…
  • Abstract Number: 2604 • 2016 ACR/ARHP Annual Meeting

    Ultrasound and Immunological Changes and Associations after One Year of IL-6/IL- 6R Blockade with Tocilizumab in Rheumatoid Arthritis Patients

    Cesar Diaz-Torne1, Juan Jose De Agustin2, Patricia Moya1, Maria A. Ortiz3, Delia Reina4, Carme Moragues5, Sergi Ros6, Emili Gomez7, Enrique Casado Burgos8, Eli Garcia9, Manel Pujol10, Maria Pilar Lisbona Perez11, Andrés Ponce12, V Torrente13, P. Estrada14, Silvia Vidal3 and ECOCAT group, 1Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, 2Rheumatology, Hospital Baix de Llobregat, Barcelona, Spain, 3Institut de Recerca Sant Pau, Barcelona, Spain, 4Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain, 5Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 6Rheumatology, Hospital de Viladecans, Viladecans, Spain, 7Rheumatology, Hospital Clínic, Barcelona, Spain, 8Hospital Universitari Parc Taulí, Sabadell, Spain, 9Rheumatology, Hospital de Mollet, Mollet, Spain, 10Hospital Mútua de Terrassa, Terrassa, Spain, 11Rheumatology, Hospital de Sabadell, Sabadell, Spain, 12Rheumatology. Internal Medicine, Hospital General de Granollers, Granollers, Spain, 13Hospital de L'Hospitalet, L'Hospitalet de Llobregat, Spain, 14Rheumatology, Hospital Moises Broggi, Barcelona, Spain

    Background/Purpose: Management of RA patients has improved in the last two decades in part with the use of ultrasound (US) in daily clinical practice. The…
  • Abstract Number: 136 • 2016 ACR/ARHP Annual Meeting

    The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis

    Sarah Ohrndorf1, Philipp Daniel Oberdorfer2, Lien Le3, Ulrich Mansmann3, Lisa Ines Sprenger2, Thomas Häupl4, Sandra Hermann2, Gabriela Schmittat2, Silvia Pade2, GR Burmester5, Anne-Marie Glimm2 and Marina Backhaus6, 1Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, 3Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität Munich, Munich, Germany, 4Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 5Charité – University Medicine Berlin, Berlin, Germany, 6Department of Rheumatology & Immunology, University Medicine Charit, Berlin, Germany

    Background/Purpose: Treatment decisions in patients with Rheumatoid Arthritis (RA) after the “Treat to Target (T2T)” - principle is widely recommended, as this management strategy leads…
  • Abstract Number: 1117 • 2016 ACR/ARHP Annual Meeting

    EGCG Down-Regulates TNF-α-Induced Mcl-1 Expression By Modulating Mule/Huwe1, β-TrCP, and USP9X Ubiquitin/De-Ubiquitin Ligases in Rheumatoid Arthritis Synovial Fibroblasts

    Nahid Akhtar1, Sadiq Umar2, David Fox3 and Salahuddin Ahmed1, 1Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, 2Department of Pharmaceutical Science, Washington State University, College of Pharmacy, Spokane, WA, 3Department of Medicine [Division of Rheumatology], University of Michigan, Ann Arbor, MI

    Background/Purpose:   Myeloid cell leukemia (Mcl-1) phosphorylation at Ser64 position (p-Mcl-1Ser64) has been shown to enhance Mcl-1’s stability and resistance to proteasomal degradation. However, the…
  • Abstract Number: 1975 • 2016 ACR/ARHP Annual Meeting

    Severity and Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis

    Yoshihisa Kobayashi1,2,3, Kei Ikeda1, Takayuki Nakamura1,4, Mieko Yamagata1,5, Takuya Nakazawa1,6, Shigeru Tanaka1, Shunsuke Furuta1, Takeshi Umibe3 and Hiroshi Nakajima1, 1Chiba University Hospital, Chiba, Japan, 2Chiba Aoba Municipal Hospital, Chiba, Japan, 3Matudo City Hospital, Matudo, Japan, 4Asahi General Hospital, Asahi, Japan, 5National Hospital Organization Shimoshizu National Hospital, Yotsukaido, Japan, 6National Hospital Organization Chiba-East Hospital, Chiba, Japan

    Background/Purpose: Morning stiffness has long been recognized by both patients and rheumatologists as a characteristic feature of rheumatoid arthritis (RA). However, morning stiffness is no…
  • Abstract Number: 2609 • 2016 ACR/ARHP Annual Meeting

    The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated up to 19 Months with Tofacitinib

    Kevin L Winthrop1, Ann Wouters2, Ernest H. Choy3,4, Chudy Nduaka2, Staci Abramsky2, Pinaki Biswas2, Lisy Wang5, Jennifer Hodge2, Irina Lazariciu6, Koshika Soma2, Christopher F Mojcik2 and William F.C Rigby7, 1Oregon Health and Sciences University, Portland, OR, 2Pfizer Inc, New York, NY, 3CREATE Center, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Great Britain, 4CREATE Center, Division of Infection and Immunity,, Cardiff University, Cardiff, United Kingdom, 5Pfizer Inc, Groton, CT, 6Quintiles, Saint-Laurent, QC, Canada, 7Geisel School of Medicine at Dartmouth, Lebanon, NH

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for herpes zoster (HZ), and vaccination is recommended in patients over the age of 50 years,…
  • Abstract Number: 144 • 2016 ACR/ARHP Annual Meeting

    Safety, Tolerability and Feasibility of Minimally Invasive Ultrasound-Guided Synovial Biopsyof Wrist and Metacarpophalangeal Joints – an Ultrasound Follow-up Study

    Laurent Meric de Bellefon1, Patrick Durez2, Christine Galant3, Adrien Nzeusseu Toukap4, Aleksandra Avramovska5, Bernard R. Lauwerys6, Frédéric A. Houssiau7 and Maria S. Stoenoiu8, 1Rheumatology, Cliniques Universitaires Saint-Luc, CHU Saint-Pierre Brussels, Clinique Notre-Dame de Grâce, Gosselies, Brussels, Belgium, 2Rheumatology, Univ Catholique de Louvain, Brussels, Belgium, 3Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 4Department of Rheumatology, Cliniques Universitaires St Luc, Brussels, Belgium, 5Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 6Department of Rheumatology, Université catholique de Louvain, Brussels, Belgium, 7Rheumatology, Pôle de Maladies Rhumatismales, Université catholique de Louvain, Brussels, Belgium, 8Service de Rhumatologie, Cliniques Universitaires Saint-Luc,Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain,, Brussels, Belgium

      Background/Purpose: The development of ultrasound-guided synovial biopsy will enable synovial tissue collection from small joints and will facilitate molecular studies, thus improving the understanding…
  • Abstract Number: 1462 • 2016 ACR/ARHP Annual Meeting

    Magnesium Is a New Mediator Arthritis Severity and Joint Damage

    Teresina Laragione, Nasim Azizgolshani, Carolyn Harris, Erjing Gao and Percio Gulko, Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose:  Given the effects of magnesium supplementation in suppressing components of the innate immunity in short-term studies, we examined the effect of dietary magnesium modifications…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 56
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology